Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis
Authors:
- Kai WangKWKai Wang
- Conghui WangCWConghui Wang
- Fangcheng XuFXFangcheng Xu
- Xiaonan ZhongXZXiaonan Zhong
- Wei QiuWQWei Qiu
- Xueqiang HuXHXueqiang Hu
- Xu F.XFXu F.
- Hu X.HXHu X.
- 1 January 2013
- journal article
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 20 (2) , 113-118
Abstract
Background: Neuromyelitis optica (NMO) and multiple sclerosis (MS) are two autoimmune inflammatory demyelinating diseases in the central nervous system. Interleukin (IL)-6 and IL-17 may play important roles in the pathogenesis of these diseases. High-mobility group box protein 1 (HMGB1) can activate the nuclear factor light chain enhancer of activated B cells and release cytokines such as IL-6 and IL-17. However, whether cerebrospinal fluid (CSF) HMGB1 levels were altered in NMO and MS patients is still unclear. Objectives: It was our aim to measure the CSF HMGB1 concentration in NMO patients and explore their relationship with IL-6, IL-17 and disease activity. Methods: CSF HMGB1 was measured by enzyme-linked immunosorbent assay in NMO (n = 22) and MS (n = 18) patients as well as in controls (n = 14). Results: CSF HMGB1 was notably higher in the NMO group compared with controls (p = 0.007). CSF HMGB1 positively correlated with IL-6 and IL-17 in NMO patients (IL-6, p = 0.034; IL-17, p < 0.001). Conclusions: In conclusion, our study suggests that CSF levels of HMGB1 are increased in patients with NMO and reflect the neuroinflammatory process.Keywords
This publication has 32 references indexed in Scilit:
- Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis OpticaNeuroimmunomodulation, 2012
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injuryBrain, 2012
- Enhanced HMGB1 Expression May Contribute to Th17 Cells Activation in Rheumatoid ArthritisJournal of Immunology Research, 2011
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and InfectionAnnual Review of Immunology, 2011
- CSF interleukin-6 level predicts recovery from neuromyelitis optica relapseJournal of Neurology, Neurosurgery & Psychiatry, 2011
- HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive NeurodegenerationJournal of Neuroscience, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- HMGB‐1 induces IL‐6 production in human synovial fibroblasts through c‐Src, Akt and NF‐κB pathwaysJournal of Cellular Physiology, 2010
- Inhibitor of NF-κB Kinases α and β Are Both Essential for High Mobility Group Box 1-Mediated ChemotaxisThe Journal of Immunology, 2010
- The Role of Toll-Like Receptors (TLR-2 and -4) and Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) in Human Term and Preterm LaborReproductive Sciences, 2009